BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 9926931)

  • 1. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
    Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
    Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
    Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
    Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
    Keren-Paz A; Bercovich Z; Kahana C
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport.
    He Y; Suzuki T; Kashiwagi K; Igarashi K
    Biochem Biophys Res Commun; 1994 Aug; 203(1):608-14. PubMed ID: 8074711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
    Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
    Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
    Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
    J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme.
    Tsuji T; Usui S; Aida T; Tachikawa T; Hu GF; Sasaki A; Matsumura T; Todd R; Wong DT
    Oncogene; 2001 Jan; 20(1):24-33. PubMed ID: 11244502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular polyamines.
    Petros LM; Graminski GF; Robinson S; Burns MR; Kisiel N; Gesteland RF; Atkins JF; Kramer DL; Howard MT; Weeks RS
    J Biochem; 2006 Nov; 140(5):657-66. PubMed ID: 16998202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
    Nilsson J; Grahn B; Heby O
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport.
    Sakata K; Fukuchi-Shimogori T; Kashiwagi K; Igarashi K
    Biochem Biophys Res Commun; 1997 Sep; 238(2):415-9. PubMed ID: 9299523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
    Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E
    Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells.
    Babál P; Ruchko M; Campbell CC; Gilmour SP; Mitchell JL; Olson JW; Gillespie MN
    J Pharmacol Exp Ther; 2001 Feb; 296(2):372-7. PubMed ID: 11160620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antizyme, a natural ornithine decarboxylase inhibitor, induces apoptosis of haematopoietic cells through mitochondrial membrane depolarization and caspases' cascade.
    Liu GY; Liao YF; Hsu PC; Chang WH; Hsieh MC; Lin CY; Hour TC; Kao MC; Tsay GJ; Hung HC
    Apoptosis; 2006 Oct; 11(10):1773-88. PubMed ID: 16927018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism.
    Kim SW; Mangold U; Waghorne C; Mobascher A; Shantz L; Banyard J; Zetter BR
    J Cell Sci; 2006 Jun; 119(Pt 12):2583-91. PubMed ID: 16735445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
    Shantz LM; Hu RH; Pegg AE
    Cancer Res; 1996 Jul; 56(14):3265-9. PubMed ID: 8764119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.